Bergh J - Search Results

1

Czene K, Bergqvist J, Hall P, Bergh J. Czene K, et al. Among authors: bergh j. Breast. 2007 Dec;16 Suppl 2:S147-54. doi: 10.1016/j.breast.2007.07.024. Breast. 2007. PMID: 18210656 Review.

2

[Adjuvant therapy of breast cancer in the USA].

Bergh J. Bergh J. Lakartidningen. 2000 Feb 23;97(8):838. Lakartidningen. 2000. PMID: 10741025 Swedish. No abstract available.

3

A population-based study on the first forty-eight breast cancer patients receiving trastuzumab (Herceptin) on a named patient basis in Sweden.

Andersson J, Linderholm B, Greim G, Lindh B, Lindman H, Tennvall J, Tennvall-Nittby L, Pettersson-Sköld D, Sverrisdottir A, Söderberg M, Klaar S, Bergh J. Andersson J, et al. Among authors: bergh j. Acta Oncol. 2002;41(3):276-81. doi: 10.1080/02841860260088827. Acta Oncol. 2002. PMID: 12195747

4

Breast-cancer prevention: is the risk-benefit ratio in favour of tamoxifen?

Bergh J. Bergh J. Lancet. 2003 Jul 19;362(9379):183-4. doi: 10.1016/S0140-6736(03)13951-7. Lancet. 2003. PMID: 12885476 No abstract available.

5

Quality of life in women with breast cancer during the first year after random assignment to adjuvant treatment with marrow-supported high-dose chemotherapy with cyclophosphamide, thiotepa, and carboplatin or tailored therapy with Fluorouracil, epirubicin, and cyclophosphamide: Scandinavian Breast Group Study 9401.

Brandberg Y, Michelson H, Nilsson B, Bolund C, Erikstein B, Hietanen P, Kaasa S, Nilsson J, Wiklund T, Wilking N, Bergh J; Scandinavian Breast Group Study 9401. Brandberg Y, et al. Among authors: bergh j. J Clin Oncol. 2003 Oct 1;21(19):3659-64. doi: 10.1200/JCO.2003.07.020. J Clin Oncol. 2003. PMID: 14512398 Clinical Trial.

6

Prognostic correlation of basic fibroblast growth factor and vascular endothelial growth factor in 1307 primary breast cancers.

Linderholm BK, Lindh B, Beckman L, Erlanson M, Edin K, Travelin B, Bergh J, Grankvist K, Henriksson R. Linderholm BK, et al. Among authors: bergh j. Clin Breast Cancer. 2003 Dec;4(5):340-7. doi: 10.3816/cbc.2003.n.039. Clin Breast Cancer. 2003. PMID: 14715109

7

Correlation test to assess low-level processing of high-density oligonucleotide microarray data.

Ploner A, Miller LD, Hall P, Bergh J, Pawitan Y. Ploner A, et al. Among authors: bergh j. BMC Bioinformatics. 2005 Mar 31;6:80. doi: 10.1186/1471-2105-6-80. BMC Bioinformatics. 2005. PMID: 15799785 Free PMC article.

8

Genetic implications of bilateral breast cancer: a population based cohort study.

Hartman M, Czene K, Reilly M, Bergh J, Lagiou P, Trichopoulos D, Adami HO, Hall P. Hartman M, et al. Among authors: bergh j. Lancet Oncol. 2005 Jun;6(6):377-82. doi: 10.1016/S1470-2045(05)70174-1. Lancet Oncol. 2005. PMID: 15925815

9

An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival.

Miller LD, Smeds J, George J, Vega VB, Vergara L, Ploner A, Pawitan Y, Hall P, Klaar S, Liu ET, Bergh J. Miller LD, et al. Among authors: bergh j. Proc Natl Acad Sci U S A. 2005 Sep 20;102(38):13550-5. doi: 10.1073/pnas.0506230102. Epub 2005 Sep 2. Proc Natl Acad Sci U S A. 2005. PMID: 16141321 Free PMC article.

10

Adjuvant chemotherapy for breast cancer--"one fits all"?

Bergh J. Bergh J. Breast. 2005 Dec;14(6):564-9. doi: 10.1016/j.breast.2005.08.020. Epub 2005 Oct 21. Breast. 2005. PMID: 16243525 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,028 results

Search Page